Hims & Hers Health Inc [HIMS] stock prices are up 0.89% to $49.85 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 18.75% over the last week, with a monthly amount drifted -4.87%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 23, 2025, when Needham downgraded its rating to a Hold. Previously, Needham reaffirmed its Buy rating on June 04, 2025, and elevated its price target to $65. On April 29, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $30 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and increased its price target to $60 on February 18, 2025. Citigroup downgraded its rating to a Sell and raised its price target to $25 on January 10, 2025. BTIG Research started tracking with a Buy rating for this stock on January 07, 2025, and assigned it a price target of $35. In a note dated December 17, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $42 on this stock.
The stock price of Hims & Hers Health Inc [HIMS] has been fluctuating between $13.47 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $49.85 at the most recent close of the market. An investor can expect a potential return of 4.31% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
The Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.78B for trailing twelve months, representing a surge of 110.67%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.36 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.53 points at the first support level, and at 47.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.98, and for the 2nd resistance point, it is at 52.10.
Ratios To Look Out For
It’s worth pointing out that Hims & Hers Health Inc [NYSE:HIMS]’s Current Ratio is 1.59. As well, the Quick Ratio is 1.32, while the Cash Ratio is 0.98. Considering the valuation of this stock, the price to sales ratio is 6.25, the price to book ratio is 20.29 and price to earnings (TTM) ratio is 72.56.
Transactions by insiders
Recent insider trading involved Boughton Soleil, Officer, that happened on Jun 30 ’25 when 2572.0 shares were purchased. Chief Financial Officer, Okupe Oluyemi completed a deal on Jun 23 ’25 to sell 23107.0 shares. Meanwhile, Officer Oluyemi Okupe bought 69431.0 shares on Jun 23 ’25.
